This inventor holds 1 USPTO granted patent. Top assignee: Academy of Military Medical Science, Pla. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Zhengshan Chen
Introduction
Zhengshan Chen is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical science, particularly in the development of monoclonal antibodies. His work is crucial in the fight against viral infections, including Ebola.
Latest Patents
Zhengshan Chen holds a patent for a monoclonal antibody known as 2G1. This antibody is designed for broad-spectrum neutralization of Ebola viruses. The patent, titled "Monoclonal antibody 2G1 for broad-spectrum neutralization of ebola viruses and application thereof," discloses a monoclonal antibody that targets the Ebola glycoprotein GP2 subunit. The antibody exhibits binding activity to various Ebola virus glycoproteins, including EBOV GP, BDBV GP, SUDV GP, and RESTV GP, demonstrating its potential to neutralize these viruses effectively.
Career Highlights
Zhengshan Chen is affiliated with the Academy of Military Medical Science, PLA. His work at this esteemed institution has allowed him to focus on innovative research and development in the field of immunology. His contributions have been recognized within the scientific community, and he continues to push the boundaries of medical research.
Collaborations
Zhengshan Chen has collaborated with notable colleagues, including Wei Chen and Changming Yu. These partnerships have fostered a collaborative environment that enhances the research and development of new medical therapies.
Conclusion
Zhengshan Chen's innovative work in developing monoclonal antibodies represents a significant advancement in medical science. His contributions are vital in the ongoing battle against viral diseases, particularly Ebola. His dedication to research and collaboration continues to inspire future innovations in the field.